港股異動丨小米集團-W(1810.HK)漲逾6% 起訴美國政府的訴訟達成和解 將被移出清單
格隆匯5月12日丨小米集團-W(1810.HK)漲逾6%,報26.1港元,總市值6579億港元。美國時間2021年5月11日,小米集團和美國國防部再次就軍事清單訴訟發佈了聯合狀態報吿。這份報吿顯示,根據此前的聯合報吿,雙方已經同意和平解決訴訟案,考慮到已經生效的臨時禁令和國防部決定不對臨時禁令上訴,國防部等被吿一致認為採用最終決議將小米集團移出1月14日的軍事清單是合適的。這意味着,美國政府承認了軍事清單上的程序正義問題,願意和小米集團進行和解,並將小米集團移出軍事清單。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.